Drug Profile
Sarpogrelate controlled release - YuYu Pharma
Alternative Names: Sarpogrelate hydrochloride - YuYu Pharma; YY-984Latest Information Update: 11 Oct 2021
Price :
$50
*
At a glance
- Originator Yuyu
- Class Antiplatelets; Butyric acids; Dimethylamines; Succinates; Vascular disorder therapies
- Mechanism of Action Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Peripheral arterial occlusive disorders
Most Recent Events
- 11 Oct 2021 Discontinued - Phase-III for Peripheral arterial occlusive disorders in South Korea (PO)
- 23 Jan 2018 Sarpogrelate controlled release is still in phase III trials for Peripheral arterial occlusive disorders in South Korea